
Alpha Profiles · Company Profile
Kiniksa Pharmaceuticals International, plc
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/kiniksa-pharmaceuticals-international-plc
- Entity
- Public listing published
- Primary listing
- NASDAQ: KNSA
- Verification
- Partially verified
- Last reviewed
- 2026-10-16T13:51:55.971604+00:00
Overview
Alpha's canonical identity and public leadership record for Kiniksa Pharmaceuticals International, plc.
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
6 public recordsExecutive Vice President and Chief Strategy Officer
- State
- confirmed
- Effective
- From Apr 16, 2026
- Confidence
- 94%
- Evidence
- KNSA DEF 14A executive officersApr 16, 2026
Executive Vice President and Chief Medical Officer
- State
- confirmed
- Effective
- From Apr 16, 2026
- Confidence
- 94%
- Evidence
- KNSA DEF 14A executive officersApr 16, 2026
Executive Vice President and Chief Financial Officer
- State
- confirmed
- Effective
- From Apr 16, 2026
- Confidence
- 94%
- Evidence
- KNSA DEF 14A executive officersApr 16, 2026
Senior Vice President, Chief Accounting Officer
- State
- confirmed
- Effective
- From Apr 16, 2026
- Confidence
- 94%
- Evidence
- KNSA DEF 14A executive officersApr 16, 2026
- State
- confirmed
- Effective
- From Apr 16, 2026
- Confidence
- 94%
- Evidence
- KNSA DEF 14A executive officersApr 16, 2026
Chief Executive Officer and Chairman of the Board
- State
- confirmed
- Effective
- From Apr 16, 2026
- Confidence
- 94%
- Evidence
- KNSA DEF 14A executive officersApr 16, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 16, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
10 public records- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2020
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2019
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2015
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2016
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
- State
- confirmed
- Effective
- From Jan 1, 2018
- Confidence
- 85%
- Evidence
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026-04-16Apr 16, 2026
Committees
2 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Thomas R. Malley
- Members
- Thomas R. Malley (Chair); G. Bradley Cole; Tracey L. McCain
Compensation
- Chair
- Kimberly J. Popovits
- Members
- Kimberly J. Popovits (Chair); Meredith S. Boyd
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-16T13:51:55.971604+00:00


